The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2306-2316
Author(s):
Lynsey G. Bilsland and Linda Greensmith
Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2401-2414
Author(s):
G. Malviya, A. Signore, B. Lagana and R. A. Dierckx
Azathioprine in Multiple Sclerosis
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
8
Page:
919-926
Author(s):
Paolo Invernizz, Maria Donata Benedetti, Sarah Poli and Salvatore Monaco
Regulation of Arylamine N-Acetyltransferases
Journal:
Current Drug Metabolism
Volume:
9
Page:
498-504
Author(s):
Neville J. Butcher, Jacky Tiang and Rodney F. Minchin
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
520-531
Author(s):
Jose A.G Agundez
The Use of Growth Factors in Hematopoietic Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1950-1961
Author(s):
I. Pusic and J. F. DiPersio
Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2051-2060
Author(s):
M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps
Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2061-2074
Author(s):
Wim J. van Blitterswijk and Marcel Verheij
Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2075-2084
Author(s):
Carlo Mischiati, Elisabetta Melloni, Federica Corallini, Daniela Milani, Carlo Bergamini and Mauro Vaccarezza
A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2085-2099
Author(s):
Silvia Sancilio, Vittorio Grill and Roberta Di Pietro